Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers 13.6 (2021): 1481.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2021
- Urheber
-
Wendel, Philipp
Reindl, Lisa Marie
Bexte, Tobias
Künnemeyer, Leander
Särchen, Vinzenz
Albinger, Nawid
Mackensen, Andreas
Rettinger, Eva
Bopp, Tobias
Ullrich, Evelyn
- DOI
-
10.3390/cancers13061481
- URN
-
urn:nbn:de:bvb:29-opus4-162025
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wendel, Philipp
- Reindl, Lisa Marie
- Bexte, Tobias
- Künnemeyer, Leander
- Särchen, Vinzenz
- Albinger, Nawid
- Mackensen, Andreas
- Rettinger, Eva
- Bopp, Tobias
- Ullrich, Evelyn
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2021
Ähnliche Objekte (12)
Unleashing the power of NK cells in anticancer immunotherapy
Mechanism and efficacy of a GD2-specific immunotherapy using NK cells
NK cell regulation
Tumor-priming converts NK cells to memory-like NK cells
Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
Current Advancements in Anti-Cancer Chimeric Antigen Receptor T Cell Immunotherapy and How Nanotechnology May Change the Game
NK cells in the liver
Use of TCR antibody fusion proteins as bispecific agents for NK and T cell-mediated immunotherapy
Mass production of highly active NK cells for cancer immunotherapy in a GMP conform perfusion bioreactor
Investigating tumor cell-specific barriers for immunotherapy
Restoring NK cells function against cancer.
Metabolics of Tissue resident NK cells
Unleashing the power of NK cells in anticancer immunotherapy
Mechanism and efficacy of a GD2-specific immunotherapy using NK cells
NK cell regulation
Tumor-priming converts NK cells to memory-like NK cells
Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
Current Advancements in Anti-Cancer Chimeric Antigen Receptor T Cell Immunotherapy and How Nanotechnology May Change the Game
NK cells in the liver
Use of TCR antibody fusion proteins as bispecific agents for NK and T cell-mediated immunotherapy
Mass production of highly active NK cells for cancer immunotherapy in a GMP conform perfusion bioreactor
Investigating tumor cell-specific barriers for immunotherapy
Restoring NK cells function against cancer.
Metabolics of Tissue resident NK cells
Unleashing the power of NK cells in anticancer immunotherapy
Mechanism and efficacy of a GD2-specific immunotherapy using NK cells
NK cell regulation
Tumor-priming converts NK cells to memory-like NK cells
Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
Current Advancements in Anti-Cancer Chimeric Antigen Receptor T Cell Immunotherapy and How Nanotechnology May Change the Game
NK cells in the liver
Use of TCR antibody fusion proteins as bispecific agents for NK and T cell-mediated immunotherapy
Mass production of highly active NK cells for cancer immunotherapy in a GMP conform perfusion bioreactor
Investigating tumor cell-specific barriers for immunotherapy
Restoring NK cells function against cancer.